食管癌的筛查、监测与预防
Screening, surveillance, and prevention for esophageal cancer.
作者信息
Tomizawa Yutaka, Wang Kenneth K
机构信息
Barrett's Esophagus Unit, Alfred Main, Gastroenterology Diagnostic Unit, St. Mary's Hospital, 200 2nd Street SW, Rochester, MN 55905, USA.
出版信息
Gastroenterol Clin North Am. 2009 Mar;38(1):59-73, viii. doi: 10.1016/j.gtc.2009.01.014.
Abstract
The incidence of esophageal cancer, especially esophageal adenocarcinoma, is increasing and its high mortality rate is a notable fact. Improving survival rates of this disease depend on earlier detection through screening and surveillance; however, standard diagnostic modalities, such as endoscopy with biopsy, have several limitations as screening tools, including low negative predictive value and relatively high cost. Recently developed biomarkers such as FISH and improved imaging techniques, may help overcome current problems and provide improved screening and surveillance for esophageal cancer.
摘要
食管癌，尤其是食管腺癌的发病率正在上升，其高死亡率是一个显著事实。提高这种疾病的生存率取决于通过筛查和监测进行早期检测；然而，标准的诊断方法，如内镜活检，作为筛查工具存在一些局限性，包括低阴性预测值和相对较高的成本。最近开发的生物标志物如荧光原位杂交（FISH）和改进的成像技术，可能有助于克服当前的问题，并为食管癌提供更好的筛查和监测。
相似文献
1
Screening, surveillance, and prevention for esophageal cancer.
Gastroenterol Clin North Am. 2009 Mar;38(1):59-73, viii. doi: 10.1016/j.gtc.2009.01.014.
2
Oesophageal carcinoma: the need for screening.
Eur J Cancer Prev. 1993 Jan;2(1):5-12.
3
Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis.
Gastrointest Endosc. 2011 Sep;74(3):610-624.e2. doi: 10.1016/j.gie.2011.05.001. Epub 2011 Jul 13.
4
Screening and surveillance for Barrett's esophagus-an unresolved dilemma.
Nat Clin Pract Gastroenterol Hepatol. 2007 Sep;4(9):470-1. doi: 10.1038/ncpgasthep0876. Epub 2007 Jul 3.
5
Screening and surveillance of Barrett's esophagus.
Dig Dis. 2009;27(1):54-7. doi: 10.1159/000210104. Epub 2009 May 8.
6
The rationale for screening and surveillance of Barrett's metaplasia.
Best Pract Res Clin Gastroenterol. 2006;20(5):829-42. doi: 10.1016/j.bpg.2006.03.009.
7
Screening and Preventive Strategies in Esophagogastric Cancer.
Surg Oncol Clin N Am. 2017 Apr;26(2):163-178. doi: 10.1016/j.soc.2016.10.004.
8
Screening for Barrett's esophagus.
Minerva Med. 2017 Feb;108(1):28-42. doi: 10.23736/S0026-4806.16.04864-3. Epub 2016 Oct 28.
9
Role of surveillance endoscopy, biopsy and biomarkers in early detection of Barrett's adenocarcinoma.
Dis Esophagus. 1997 Jul;10(3):165-71. doi: 10.1093/dote/10.3.165.
10
[Barrett syndrome and risk of carcinoma. To screen or not to screen--that is the question].
Z Gastroenterol. 1997 Jul;35(7):597-9.
引用本文的文献
1
Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.
Microbiol Spectr. 2024 May 2;12(5):e0401223. doi: 10.1128/spectrum.04012-23. Epub 2024 Mar 18.
2
Clinical evaluation of 4 types of microRNA in serum as biomarkers of esophageal squamous cell carcinoma.
Oncol Lett. 2018 Jul;16(1):1196-1204. doi: 10.3892/ol.2018.8720. Epub 2018 May 16.
3
Barrett's Esophagus.
Curr Treat Options Gastroenterol. 2014 Jun;12(2):169-82. doi: 10.1007/s11938-014-0012-0.
4
1H-NMR based metabonomic profiling of human esophageal cancer tissue.
Mol Cancer. 2013 Apr 4;12:25. doi: 10.1186/1476-4598-12-25.
5
ABL regulation by AXL promotes cisplatin resistance in esophageal cancer.
Cancer Res. 2013 Jan 1;73(1):331-40. doi: 10.1158/0008-5472.CAN-12-3151. Epub 2012 Nov 1.
6
Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development.
Therap Adv Gastroenterol. 2012 Sep;5(5):285-99. doi: 10.1177/1756283X12446668.
7
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.
Cancer Biol Ther. 2010 Nov 15;10(10):1009-18. doi: 10.4161/cbt.10.10.13248.
本文引用的文献
1
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age.
J Natl Cancer Inst. 2008 Aug 20;100(16):1184-7. doi: 10.1093/jnci/djn211. Epub 2008 Aug 11.
2
Fruit and vegetable consumption and squamous cell carcinoma of the esophagus in Japan: the JPHC study.
Int J Cancer. 2008 Oct 15;123(8):1935-40. doi: 10.1002/ijc.23744.
3
Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.
Am J Gastroenterol. 2008 Mar;103(3):788-97. doi: 10.1111/j.1572-0241.2008.01835.x.
4
Cancer statistics, 2008.
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
5
Squamous dysplasia and other precursor lesions related to esophageal squamous cell carcinoma.
Gastroenterol Clin North Am. 2007 Dec;36(4):797-811, v-vi. doi: 10.1016/j.gtc.2007.08.005.
6
Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system.
Gut. 2008 Feb;57(2):167-72. doi: 10.1136/gut.2007.134213. Epub 2007 Oct 26.
7
Fluorescence in situ hybridization in diagnostic cytology.
Hum Pathol. 2007 Aug;38(8):1137-44. doi: 10.1016/j.humpath.2007.04.015.
8
Esophageal cancer: cases and causes (part I).
Endoscopy. 2007 Jun;39(6):550-5. doi: 10.1055/s-2007-966530.
9
Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux.
Gastrointest Endosc. 2007 Apr;65(4):577-83. doi: 10.1016/j.gie.2006.06.035. Epub 2007 Feb 26.
10
Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett's adenocarcinoma.
Gastrointest Endosc. 2007 Jan;65(1):36-46. doi: 10.1016/j.gie.2006.03.938.
Zotero 插件